Prot# 24779: A Double-Blind, Prospective, Randomized, Placebo-Controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto-CD34+ Cells for Reduction of Angina Episodes in

Project: Research project

Project Details

StatusFinished
Effective start/end date2/22/071/6/12

Funding

  • PPD Development (24779 // 24779)
  • Baxter Healthcare Corporation (24779 // 24779)